ArticlemAbs

Agonistic TAM-163 antibody targeting tyrosine kinase receptor-B: applying mechanistic modeling to enable preclinical to clinical translation and guide clinical trial design.

Yulia Vugmeyster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.